To determine the potential impact of eIF4F inhibition on the ERK MAPK signaling pathway activity in melanoma, we analyzed the levels of active MEK and ERK kinases in RocA-treated A375 and MelJuso cells by SDS-PAGE and Western blotting. This evidence concerns the gene MAP2K7 and melanoma.